Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Verastem Inc., 3 years.
Verastem Inc.
Director
Axogen Inc.
Director
Xeris Biopharma Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2024 | Verastem Inc. | Grant or award | +8,333 | — | — |
| Jun 6, 2024 | Axogen Inc. | Grant or award | +10,653 | — | — |
| Jun 5, 2024 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Mar 18, 2024 | Xeris Biopharma Holdings Inc. | Option exercise | +215,600 | $1.99 | $429,044 |
| Mar 15, 2024 | Xeris Biopharma Holdings Inc. | Other | +89,571 | — | — |
| Jun 7, 2023 | Xeris Biopharma Holdings Inc. | Grant or award | +42,500 | — | — |
| Jun 1, 2023 | Axogen Inc. | Option exercise | +6,459 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.